How Does Multiple Sclerosis Affect the Digestive System?

Multiple sclerosis disrupts the digestive system at nearly every level, from swallowing to bowel control, because the same nerve damage that causes the disease’s hallmark motor and sensory symptoms also reaches the networks that keep the gut moving. MS produces lesions in the central nervous system that disturb both voluntary movement and the autonomic pathways governing digestion.¹ Research now suggests the enteric nervous system, the mesh of neurons lining the gut wall, may itself be an autoimmune target in the disease.² The result is a wide spectrum of gastrointestinal problems that often go underreported and undertreated.

Why MS Reaches the Gut

Digestion depends on coordinated signals between the brain, the spinal cord, and the enteric nervous system. MS lesions can interrupt any part of that chain. When lesions form in the brainstem, they can impair the nerves responsible for swallowing. When they appear in the spinal cord, they can slow or disorganize the reflexes that move food through the intestines and control the anal sphincter. And because MS is an inflammatory autoimmune disease, the immune attack is not necessarily confined to the brain and spinal cord.

In a mouse model of MS, researchers found that degeneration of the enteric nervous system appeared before central nervous system lesions even developed and before any neurological symptoms began. The damage was driven by antibodies that targeted proteins in the gut’s own neurons and glial cells, and it produced a measurable drop in gastrointestinal motility.² Separate work in the same animal model confirmed that autoantibodies from both MS patients and experimental mice targeted enteric neurons and glia, and that removing B cells from the equation protected against colonic dysmotility.³ These findings raise the possibility that some gut symptoms in MS are not just a downstream consequence of brain and spinal lesions but a parallel autoimmune process happening right in the gut wall.

Trouble Swallowing

Dysphagia, difficulty swallowing, is one of the most common upper-GI problems in MS. Across all patients in one large study, about one in four had dysphagia. The rates climbed sharply in people with progressive forms of the disease: roughly 44% of those with secondary progressive MS and 43% of those with primary progressive MS reported swallowing difficulties, compared with about 22% in relapsing-remitting MS.⁴ Higher disability scores, cerebellar impairment, and motor dysfunction all increased the risk.

Swallowing problems can show up in subtle ways long before someone starts coughing on liquids. Food may feel like it is sticking in the throat. Meals take longer. Some people unconsciously avoid certain textures. Over time these changes raise the risk of aspiration pneumonia, which occurs when food or liquid enters the airway, and can lead to inadequate nutrition if eating becomes stressful enough that people simply eat less.

Stomach Emptying Gone Haywire

Below the throat, the stomach has its own motility problems. Gastroparesis, where the stomach empties too slowly, has been documented in MS patients with abnormal gastric emptying tests.⁵ Symptoms include nausea, bloating, early fullness, and sometimes vomiting after meals.

Interestingly, the stomach does not always slow down. A single-center motility study found delayed gastric emptying at four hours in about 16% of MS patients but accelerated gastric emptying in 22%.⁶ Accelerated emptying can cause dumping of partially digested food into the small intestine, triggering cramps, diarrhea, and dizziness after eating. The same study found delayed colonic transit at 24 hours in about 7% of patients, suggesting the motility disruption can affect different segments of the GI tract independently. This unpredictability makes digestive symptoms in MS frustratingly inconsistent from one person to the next, and even from one flare to the next in the same person.

Constipation, Fecal Incontinence, and the Overlap Between Them

Bowel dysfunction is the digestive complaint that people with MS deal with most often and talk about least. Constipation and fecal incontinence can each occur on their own, but they also coexist and alternate in ways that feel contradictory.⁷ A person can go days without a bowel movement and then experience sudden urgency or leakage. The underlying cause is the same: damaged nerve signals no longer coordinate the colonic and anorectal muscles properly.

Transit studies paint a vivid picture. In one group of MS patients with fecal incontinence, large-bowel transit was abnormally slow in 82%, with the delay concentrated in the distal colon.⁸ Animal models mirror this: mice with MS-like disease developed reduced colonic motility, less frequent colonic contractions, and drier stool due to lower fecal water content.³

Bowel, bladder, and sexual dysfunctions cluster together as pelvic floor disorders in MS, and the combination takes a heavy toll on daily life and mobility. Higher neurogenic bowel dysfunction scores have been linked to greater disability, worse fatigue, more urinary symptoms, and lower physical quality-of-life scores.⁹ People often plan their entire day around bathroom access, avoid social outings, or reduce physical activity out of fear of an accident. The embarrassment factor means many patients never bring up bowel symptoms with their neurologist, which delays intervention.

The Gut Microbiome in MS

The bacteria living in the gut are not passive bystanders in MS. Multiple studies have found that the microbial community in people with MS looks measurably different from that of healthy controls. One study found that MS patients had significantly lower levels of Bacteroides fragilis and Bifidobacterium species, both of which are considered anti-inflammatory, while a trend toward reduced Faecalibacterium prausnitzii did not quite reach statistical significance. Treatment-naïve patients showed the starkest differences, suggesting the shift in gut bacteria is present early rather than being purely a side effect of medication.¹⁰

Another study found that 21 bacterial species differed significantly between MS patients and controls, with 19 of them less abundant in the MS group. The losses were especially concentrated among bacteria in certain Clostridia clusters known to produce anti-inflammatory metabolites.¹¹ The practical consequence of this microbial imbalance may involve increased intestinal permeability, sometimes called “leaky gut.” Biomarkers of gut-barrier integrity are altered in MS, and one such marker, zonulin, has been associated with disease progression in progressive MS and appears to mirror blood-brain barrier breakdown in relapsing-remitting MS.¹²

A key part of this story involves short-chain fatty acids, the molecules that gut bacteria produce when they ferment dietary fiber. In long-term progressive MS patients, blood levels of the major short-chain fatty acids (acetate, propionate, and butyrate) are significantly decreased.¹³ These molecules help regulate immune cells and support the integrity of both the gut lining and the blood-brain barrier. Their depletion fits with the broader observation that MS patients consistently lose the bacterial species responsible for producing them.¹⁴ Whether the altered microbiome helps trigger MS or is itself a consequence of the disease remains an open question.¹⁵ Either way, it adds a layer of complexity to digestive symptoms that goes well beyond slowed transit or a weak sphincter.

When MS Medications Add to the Problem

Some of the drugs used to slow MS progression carry their own gastrointestinal side effects, and for people already dealing with a gut that does not work well, those side effects can be hard to tease apart from the disease itself. Oral disease-modifying therapies, which many patients prefer over injections, are among the worst offenders. In one qualitative study, patients on oral drugs reported 16 different types of GI symptoms, with diarrhea, indigestion, and nausea topping the list. Most still said the trade-off was worth it because the drugs reduced relapses and slowed progression.¹⁶

Dimethyl fumarate, one of the most widely prescribed oral MS drugs, is a well-known source of stomach trouble. In a head-to-head trial, a newer formulation called diroximel fumarate produced GI side effects in about 35% of patients compared with 49% on dimethyl fumarate, and far fewer people quit the newer drug because of stomach problems.¹⁷ If you are on an oral MS therapy and your gut symptoms worsened around the time you started it, that distinction matters: the problem may be the pill, not disease progression, and switching formulations or adjusting timing can help.

MS and Inflammatory Bowel Disease

People with MS have a higher-than-expected chance of also having inflammatory bowel disease, and the reverse is true as well. A meta-analysis pooling data from multiple registries found that both groups carry roughly a 50% increased risk of being diagnosed with the other condition compared with the general population.¹⁸ The overlap held for both Crohn’s disease and ulcerative colitis. The shared link likely involves overlapping immune pathways and genetic susceptibility rather than one disease causing the other, but the practical implication is straightforward: if you have MS and develop persistent bloody stools, unexplained weight loss, or chronic abdominal pain that does not fit the usual neurogenic-bowel pattern, an inflammatory bowel disease workup is worth discussing with your doctor.

Managing Neurogenic Bowel Dysfunction

Treatment usually starts with the basics: dietary fiber, adequate fluid intake, scheduled toilet times, and physical activity to the extent someone’s mobility allows. When those measures fall short, transanal irrigation, which involves flushing the lower bowel with water through a rectal catheter, has shown consistent benefits. In one study, constipation and incontinence scores both improved significantly after six weeks of treatment.¹⁹

Longer-term data are encouraging but mixed. In a follow-up study averaging about 40 months, 55% of patients were still using transanal irrigation. Severe bowel dysfunction dropped from 47% at baseline to 18%. The main predictor of whether someone would stick with the therapy and benefit from it was a specific nerve-sensitivity finding in the anal canal.²⁰ A separate study looking at neurogenic bowel scores found the greatest improvements in people who started with moderate dysfunction; those who began with severe dysfunction tended to stay in the severe category despite treatment.²¹ The takeaway is that intervening before bowel dysfunction becomes severe gives the best chance of meaningful relief.

Pelvic-floor rehabilitation is another option that has drawn research interest. A pilot study of individualized physiotherapy for anorectal dysfunction in MS patients found that symptom scores improved significantly over the course of supervised treatment and remained improved during a self-treatment phase afterward.²² The improvements showed up in how people rated their symptoms rather than in the pressure readings from manometry, which suggests the therapy helps people manage their symptoms more effectively even if the underlying muscle dysfunction persists.

Nutritional Consequences

When swallowing is difficult, the stomach empties erratically, and bowel function is unreliable, nutrition inevitably suffers. Research on nutritional status in MS patients has not been extensive, but what exists paints a concerning picture: many patients experience various forms of malnutrition, which in turn can impair immune function, weaken respiratory muscles, and affect cognitive performance.²³ People with significant dysphagia may avoid protein-rich foods that require more chewing, while those with chronic constipation may limit fiber in a misguided effort to reduce bloating, inadvertently starving the very gut bacteria whose loss compounds the problem.

Fatigue, one of the most disabling symptoms of MS, further complicates eating. Preparing meals from scratch requires energy many patients do not have, pushing them toward processed convenience foods that are low in fiber and high in salt. The interplay between gut symptoms, fatigue, poor diet, and worsening gut microbial health can become a self-reinforcing cycle that is hard to break without deliberate attention from the care team.

When GI Symptoms Overlap with Pregnancy

MS is most commonly diagnosed in women of childbearing age, which creates a diagnostic wrinkle. Fatigue, urinary frequency, constipation, and mood changes are common in both MS and pregnancy.²⁴ During pregnancy, GI symptoms that a person has been attributing to their MS may intensify simply because of the hormonal and mechanical changes of carrying a child, or new GI symptoms caused by pregnancy may be mistakenly chalked up to an MS flare. Sorting out which symptoms belong to which condition matters because the management strategies differ: an MS-related motility problem might warrant a medication change, while a pregnancy-related one might resolve on its own after delivery. Open communication with both a neurologist and an obstetrician is essential during this period, especially since many MS medications are stopped or switched during pregnancy, which can itself change how the gut behaves.

Getting Gut Symptoms Taken Seriously

One of the persistent problems in MS care is that bowel and stomach symptoms are treated as secondary concerns, overshadowed by the more dramatic neurological manifestations like vision loss, weakness, or difficulty walking. Bowel dysfunction tends to worsen over the course of the disease and requires ongoing, adapted interventions rather than a single conversation and a fiber recommendation.²⁵ Yet many people never receive a formal assessment of their GI function. Anorectal manometry, a test that measures pressures and reflexes in the rectum and anal canal, can characterize the specific type of sphincter dysfunction a patient has and guide treatment choices.²⁶ Gastric emptying studies can distinguish delayed from accelerated emptying, which require opposite management approaches. These tests are available but underused in MS populations.

If you or someone you care for has MS and deals with persistent nausea, bloating, constipation, unpredictable bowel habits, or difficulty swallowing, those symptoms deserve direct attention rather than being folded into a general “living with MS” conversation. The evidence is clear that digestive problems in MS are not minor inconveniences. They affect how well medications are absorbed, how much nutrition the body gets, how freely a person can participate in social life, and ultimately how the disease itself progresses.